Defective antioxidant systems in cervical cancer

Tumor Biology

Volumn 34, Issue 4, 2013, Pages 2003-2009

  Jiang, Bin ^a   Xiao, Songshu ^a   Khan, Md Asaduzzaman ^b   Xue, Min ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Antioxidant enzymes; Antioxidant vitamins; Cancer therapy; Cervical cancer; Human papilloma virus infection

Indexed keywords

2 O BETA DEXTRO GLUCOPYRANOSYLASCORBIC ACID; ALOIN; ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ASCORBIC ACID DERIVATIVE; BETA CAROTENE; CATALASE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; POLYPHENOL; QUERCETIN; RESVERATROL; RETINOL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER RISK; CARCINOGENESIS; CUMIN; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; LYCIUM BARBARUM; MORINDA CITRIFOLIA; NONHUMAN; OXIDATIVE STRESS; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK FACTOR; SOYBEAN; UTERINE CERVIX CANCER;

EID: 84881475719     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0804-1     Document Type: Article

References (63)

1. Canavan TP, Doshi NR. Cervical cancer. Am Fam Physician. 2000;61:1369-76.
2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461-84.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9.
5. Srivastava S, Natu SM, Gupta A, Pal KA, Singh U, Agarwal GG, et al. Lipid peroxidation and antioxidants in different stages of cervical cancer: prognostic significance. Indian J Cancer. 2009;46:297-302.
6. Manoharan S, Kolanjiappan K, Kayalvizhi M. Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma. Cell Mol Biol Lett. 2004;9:699-707.
7. Manju V, Kalaivani Sailaja J, Nalini N. Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. Clin Biochem. 2002;35:621-5.
8. Gonçalves TL, Erthal F, Corte CL, Müller LG, Piovezan CM, Nogueira CW, et al. Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women. Clin Biochem. 2005;38:1071-5.
9. Sharma A, Rajappa M, Saxena A, Sharma M. Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci. 2007;64:23-7.
10. Fuchs-Tarlovsky V, Rivera MA, Altamirano KA, Lopez-Alvarenga JC, Ceballos-Reyes GM. Antioxidant supplementation has a positive effect on oxidative stress and hematological toxicity during oncology treatment in cervical cancer patients. Support Care Cancer. 2013;21:1359-63.
11. Khan MA, Tania M, Zhang DZ, Chen HC. Antioxidant enzymes and cancer. Chin J Cancer Res. 2010;22:87-92.
12. Chen X, Ding YW, Yang G, Bondoc F, Lee MJ, Yang CS. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis. 2000;21:257-63.
13. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84.
14. Kulbacka J, Saczko J, Chwiłkowska A. Oxidative stress in cells damage processes. Pol Merkur Lekarski. 2009;27:44-7.
15. Balasubramaniyan N, Subramanian S, Govindasamy S. Status of antioxidant systems in human carcinoma of uterine cervix. Cancer Lett. 1994;87:187-92.
16. Maldonado PA, Negrini LA, Kaizer RR, Zanin RF, Araújo Mdo C, Battisti V, et al. Oxidative status in patients submitted to conization and radiation treatments for uterine cervix neoplasia. Clin Chim Acta. 2006;366(1-2):174-8.
17. Kolanjiappan K, Manoharan S, Kayalvizhi M. Measurement of erythrocytes lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta. 2002;326:143-9.
18. Manoharan S, Kolanjiappan K, Kayalvizhi M. Lipid peroxidation and antioxidant status in cervical cancer patients. J Biochem Mol Biol Biophys. 2002;6:225-7.
19. Kim SY, Kim JW, Ko YS, Koo JE, Chung HY, Lee-Kim YC. Changes in lipid peroxidation and antioxidant trace elements in serum of women with cervical intraepithelial neoplasia and invasive cancer. Nutr Cancer. 2003;47:126-30.
20. Naidu MS, Suryakar AN, Swami SC, Katkam RV, Kumbar KM. Oxidative stress and antioxidant status in cervical cancer patients. Indian J Clin Biochem. 2007;22:140-4.
21. Chung-man HJ, Zheng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res. 2001;61:8578-85.
22. Plymate SR, Haugk KH, Sprenger CC, Nelson PS, Tennant MK, Zhang Y, et al. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1. Oncogene. 2003;22:1024-34.
23. Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene. 2005;24:367-80.
24. Kazbariene B, Prasmickiene G, Krikstaponiene A, Sukeliene D, Burneckis A, Didziapetriene J. Changes in the parameters of immune and antioxidant systems in patients with cervical cancer. Medicina (Kaunas). 2004;40:1158-64.
25. Demirci S, Ozsaran Z, Celik HA, Aras AB, Aydin HH. The interaction between antioxidant status and cervical cancer: a case control study. Tumori. 2011;97:290-5.
26. Grace Nirmala J, Narendhirakannan RT. Detection and genotyping of high-risk HPV and evaluation of anti-oxidant status in cervical carcinoma patients in Tamil Nadu State, India - a case control study. Asian Pac J Cancer Prev. 2011;12:2689-95.
27. Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta. 2007;375:119-23.
28. WoÅniak B, Mila-Kierzenkowska C, Kedziora-Kornatowska K, Drewa T, Drewa G, WoÅniak A, et al. Influence of the management of cervical carcinoma on the activity of catalase and glutathione peroxidase in erythrocytes. Eur J Gynaecol Oncol. 2007;28:461-3.
29. Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711-60.
30. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. 2003;66:1499-503.
31. Mannervik B. The enzymes of glutathione metabolism: an overview. Biochem Soc Trans. 1987;15:717-8.
32. Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 1988;263:17205-8.
33. Krishna PB, Govindasamy M. Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Acc Chem Res. 2010;43:1408-19.
34. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi Y. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal. 2004;6:289-300.
35. Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev. 2011;43:138-51.
36. Bhuvarahamurthy V, Balasubramanian N, Govindasamy S. Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Mol Cell Biochem. 1996;158:17-23.
37. Mila-Kierzenkowska C, Kedziora-Kornatowska K, WoÅniak A, Drewa T, WoÅniak B, Drewa S, et al. The effect of brachytherapy on antioxidant status and lipid peroxidation in patients with cancer of the uterine cervix. Cell Mol Biol Lett. 2004;9:511-8.
38. Traber MG, Stevens JF. Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med. 2011;51:1000-13.
39. Gao LB, Pan XM, Li LJ, Liang WB, Bai P, Rao L, et al. Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS One. 2011;6:e20157.
40. De Marco F, Bucaj E, Foppoli C, Fiorini A, Blarzino C, Filipi K, et al. Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS One. 2012;7:e34366.
41. Fan X, Liu Y, Heilman SA, Chen JJ. Human papillomavirus E7 induces rereplication in response to DNA damage. J Virol. 2013;87:1200-10.
42. Oliveira S, Ribeiro J, Sousa H, Pinto D, Baldaque I, Medeiros R. Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G. Oncol Rep. 2012;27:1188-92.
43. Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol. 2011;6:45-57.
44. KwaÅniewska A, Tukendorf A, Semczuk M. Frequency of HPV infection and GSH levels in plasma of women with cervical dysplasia. Eur J Gynaecol Oncol. 1997;18:196-9.
45. Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev. 1999;4:304-29.
46. Fuchs-Tarlovsky V. Role of antioxidants in cancer therapy. Nutrition. 2013;29:15-21.
47. Hart C, Cohen R, Norwood M, Stebbing J. The emerging harm of antioxidants in carcinogenesis. Future Oncol. 2012;8:535-48.
48. Di Domenico F, Foppoli C, Coccia R, Perluigi M. Antioxidants in cervical cancer: chemopreventive and chemotherapeutic effects of polyphenols. Biochim Biophys Acta. 1822;2012:737-47.
49. Singh M, Mendez E, Rao AR, Kale RK. Chemomodulatory potential of Glycine max against murine skin and cervical papillomagenesis. Indian J Exp Biol. 2011;49:864-70.
50. De S, Chakraborty J, Chakraborty RN, Das S. Chemopreventive activity of quercetin during carcinogenesis in cervix uteri in mice. Phytother Res. 2000;14:347-51.
51. Kim YS, Sull JW, Sung HJ. Suppressing effect of resveratrol on the migration and invasion of human metastatic lung and cervical cancer cells. Mol Biol Rep. 2012;39:8709-16.
52. Dhandayuthapani S, Marimuthu P, Hörmann V, Kumi-Diaka J, Rathinavelu A. Induction of apoptosis in HeLa cells via caspase activation by resveratrol and genistein. J Med Food. 2013;16:139-46.
53. Khan MA, Chen HC, Wan XX, Tania M, Xu AH, Chen FZ, et al. Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells. Mol Cells. 2013;35:219-25.
54. Sharma C. Nusri Qel-A, Begum S, Javed E, Rizvi TA, Hussain A. (-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells. Asian Pac J Cancer Prev. 2012;13:4815-22.
55. Nićiforović A, Adzić M, Spasić SD, Radojcić MB. Antitumor effects of a natural anthracycline analog (Aloin) involve altered activity of antioxidant enzymes in HeLaS3 cells. Cancer Biol Ther. 2007;6:1200-5.
56. Gagandeep, Dhanalakshmi S, Méndiz E, Rao AR, Kale RK. Chemopreventive effects of Cuminum cyminum in chemically induced forestomach and uterine cervix tumors in murine model systems. Nutr Cancer. 2003;47:171-80.
57. Khan MA, Tania M, Zhang DZ, Chen HC. Anticancer activities of Nigella sativa (black cumin). Afr J Tradit Complement Altern Med. 2011;8:226-32.
58. Zhang Z, Liu X, Wu T, Liu J, Zhang X, Yang X, et al. Selective suppression of cervical cancer Hela cells by 2-O-β-d-glucopyranosyl-l- ascorbic acid isolated from the fruit of Lycium barbarum L. Cell Biol Toxicol. 2011;27:107-21.
59. Thani W, Vallisuta O, Siripong P, Ruangwises N. Anti-proliferative and antioxidative activities of Thai noni/Yor (Morinda citrifolia Linn.) leaf extract. Southeast Asian J Trop Med Public Health. 2010;41:482-9.
60. Singh VN, Gaby SK. Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation. Am J Clin Nutr. 1991;53:386S-90.
61. Kim J, Kim MK, Lee JK, Kim JH, Son SK, Song ES, et al. Intakes of vitamin A, C, and E, and beta-carotene are associated with risk of cervical cancer: a case-control study in Korea. Nutr Cancer. 2010;62:181-9.
62. Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutr Cancer. 2008;60:331-41.
63. Myung SK, Ju W, Kim SC, Kim H, Korean Meta-analysis (KORMA) Study Group. Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis. BJOG. 2011;118:1285-91.